Invest now
Aarey Drugs & Pharmaceuticals Ltd share price
High risk
You have to be logged in to add this to Watchlist.- ₹82.75(-2.65%)August 7, 2026 15:28:34 PM IST
- NSE
- BSE
- Vol : 8.22 K (NSE + BSE)Last 20 day avg : 50.12 K
Aarey Drugs & Pharmaceuticals Ltd is trading -2.65% lower at Rs 82.75 as compared to its last closing price. Aarey Drugs & Pharmaceuticals Ltd has been trading in the price range of 83.99 & 81.00. Aarey Drugs & Pharmaceuticals Ltd has given 20.88% in this year & 6.07% in the last 5 days. Aarey Drugs & Pharmaceuticals Ltd has TTM P/E ratio 31.92 as compared to the sector P/E of 30.34.The company posted a net profit of 1.56 Crores in its last quarter.Listed peers of Aarey Drugs & Pharmaceuticals Ltd include Sun Pharmaceutical Industries (0.26%), Divi's Laboratories (-0.52%), Torrent Pharmaceuticals (-0.26%).The Mutual Fund holding in Aarey Drugs & Pharmaceuticals Ltd was at -% in . The MF holding has - from the last quarter. The FII holding in Aarey Drugs & Pharmaceuticals Ltd was at 4.81% in 30 Jun 2026. The FII holding has increased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
- 1 D
- 5 D
- 1 M
- 3 M
- 6 M
- 1 Y
- 5 Y
- MAX
Loading...
Key Metrics
Updated on 09 Aug 2026, 09:15 AM IST
- BetaHigh volatility2.49Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityHigher than industry0.33The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldLower than industry0.00Annual dividends as a percentage of the stock price.
- P/BHigher than historical values1.55The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values51.44Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates undervaluation-22.47The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
Price range
Day Range
|
| ||||
52 week range
|
| ||||
Aarey Drugs & Pharmaceuticals Ltd Peers
Return Comparison
Peers Comparison
Names | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | 1,949.00 | 0.26 | 4,67,619.37 | 38.40 | 5.55 | 0.83 | 0.47 |
| Divi's Laboratories | 8,248.50 | -0.52 | 2,18,971.76 | 73.32 | 11.48 | 0.41 | 0.03 |
| Torrent Pharmaceuticals | 4,952.00 | -0.26 | 1,88,351.43 | 72.73 | 19.22 | 0.80 | 141.16 |
| Cipla | 1,472.00 | -0.20 | 1,18,914.83 | 27.57 | 3.33 | 0.92 | 1.11 |
| Zydus Lifesciences | 1,115.20 | 0.81 | 1,11,241.63 | 21.19 | 4.24 | 0.09 | 14.22 |
Aarey Drugs & Pharmaceuticals Ltd Corporate Actions
View all- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-05-30 | Audited Results |
| 2026-05-29 | Audited Results |
| 2026-02-11 | Quarterly Results |
| 2025-11-13 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
About the company Aarey Drugs & Pharmaceuticals Ltd
- IndustryBiotechnology & Drugs
- ISININE198H01019
- BSE Code524412
- NSE CodeAAREYDRUGS
Aarey Drugs and Pharmaceuticals Limited is an India-based company, which is engaged in the manufacturing and trading of drugs and pharmaceuticals. The Company is in active pharmaceutical ingredients (API)/bulk drug manufacturing and offers a range of products for various industrial applications. Its products include N-Methyl Urea, Mefenamic acid, Doxofylline, Lumefantrine, Nimesulide, Albendazole, Carbamazepine and Oxcarbazepine. The Company's chemical and solvents include Aeromatics Chemical, Chemical acid, Chlor Alkali, Industrial Alchols, Industrial Ketones, Glycols and Glycol Ethers, Fiber Intermediates, Industrial Amines, Acetates and Esters, Industrial Oleochemicals, Industrial Intermediates, Chlorinated Solvents, Industrial Olefines, Industrial Phosphates, Industrial Fertilizers, Industrial Monomers and Industrial Chemicals. Its chemical acid products include Acetic acid, Citric acid, Formic acid and Hydrochloric acid.
Aarey Drugs & Pharmaceuticals Ltd Share Price FAQs
Aarey Drugs & Pharmaceuticals Ltd is trading at 82.75 as on Fri Aug 07 2026 09:58:34. This is -2.65% lower as compared to its previous closing price of 85.00.
The market capitalization of Aarey Drugs & Pharmaceuticals Ltd is 234.63 Cr as on Fri Aug 07 2026 09:58:34.
The 52 wk high for Aarey Drugs & Pharmaceuticals Ltd is 100.00 whereas the 52 wk low is 50.40
Aarey Drugs & Pharmaceuticals Ltd can be analyzed on the following key metrics -
- TTM P/E: 31.92
- Sector P/E: 30.34
- Dividend Yield: 0.00%
- D/E ratio: 0.33
Aarey Drugs & Pharmaceuticals Ltd reported a net profit of 3.97 Cr in 2026.
Quick Links
EQUITY QUICK LINKS
Aarey Drugs & Pharmaceuticals Ltd QUICK LINKS
FROM MARKETS
RELATED LINKS
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.